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Abstract
Blood vessels constantly subjected to mechanical stress have well-developed
elastic fiber-rich frameworks, which contribute to the elasticity and distensibility
of the vascular wall. Destruction of the fibrous structure due to genetic predispo-
sition as well as acquired disorders such as Kawasaki disease often induces
irreversible dilation of blood vessels, e.g., aneurysm formation. In addition to
their structural role, extracellular matrix molecules also provide important
biological signaling, which influences various cellular functions. Among them,
increased attention has been focused on matricellular proteins, a group of non-
structural extracellular matrix (ECM) proteins highly upregulated in active tissue
remodeling, serving as biological mediators by interacting directly with cells or
regulating the activities of growth factors, cytokines, proteases, and other ECM
molecules. Tenascin-C (TNC) is a typical matricellular protein expressed during
embryonic development and tissue repair/regeneration in a spatiotemporally
restricted manner. Various growth factors, pro-inflammatory cytokines, and
mechanical stress upregulate its expression. TNC controls cell adhesion, migra-
tion, differentiation, and synthesis of ECM molecules. Our recent results suggest
that TNCmay not only play a significant role in the recruitment of smooth muscle/
mural cells during vascular development, but also regulate the inflammatory
response during pathological remodeling. TNC may be a key molecule during
vascular development, adaptation, and pathological tissue remodeling.
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Tissue, including the cardiovascular system, is composed of diverse cells and the
extracellular matrix (ECM) synthesized by those cells. Several ECM molecules
form a fibrous framework and provide structural support for the tissue. Blood
vessels constantly subjected to mechanical stress have a well-developed fibrous
framework, which contributes to the elasticity and distensibility of the vascular wall
in concert with vascular smooth muscle cells. Highly ordered structures consisting
of cells and fibrous elements are formed during development and are remodeled
during tissue repair/regeneration after injury. In addition to their physical role,
several ECM molecules provide important biological signaling, which influences
various cellular functions in physiological and pathological tissue remodeling. In
particular, ECM, termed matricellular protein, has attracted increasing attention as
a biological mediator. Tenascin-C (TNC) is a prototype matricellular protein
expressed during embryonic development and tissue repair after injury. This chap-
ter will focus on the role of TNC in vascular development, especially coronary
arteries and the aorta.
29.2 Extracellular Matrix in Vascular Wall
Blood vessels have abundant fibrous matrix tissue: well-developed elastic fibers in
the medial layer and rich collagen fibers in adventitia. It is known that several gene
mutations related to these fibrous components cause vascular fragility, eventually
leading to aneurysm formation or dissection. For example, the collagen gene and
fibrillin-1 gene, which is important for microfibril formation, have been identified
as the genes responsible for Ehlers-Danlos syndrome (reviewed in [1]) and
Marfan’s syndrome [2], respectively. In addition to genetic predisposition, inflam-
mation of blood vessels in acquired disease may induce fragmentation and destruc-
tion of normal elastic fibers in the vascular wall and causes irreversible dilation of
blood vessels. For example, coronary aneurysm formation is sometimes seen in
patients with Kawasaki vasculitis, one of the most common acquired heart diseases
in children. Evidently, the structural support by fibrous ECM is essential to main-
tain the proper morphology and function of blood vessels.
Besides these fibrous elements, unique ECM molecules, matricellular protein
[3], have attracted considerable attention. The matricellular proteins have common
unique properties: (1) do not contribute directly to structures such as fibrils or
basement membranes; (2) high levels of expression during embryonic development
and in response to injury; and (3) binding to many cell surface receptors,
components of ECM, growth factors, cytokines, and proteases [4]. This is a growing
family originally including SPARC, tenascin, and thrombospondin [3].
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29.3 Tenascin-C in Vascular System
Tenascins are a family of four multimeric extracellular matrix glycoproteins:
tenascin-C, X, R, and W [5]. The first member, tenascin-C (TNC), is a typical
matricellular protein. It is a huge molecule of about 220–400 kDa as an intact
monomer and is assembled with a hexamer. The molecule consists of an N-terminal
assembly domain, followed by EGF-like repeats, constant and alternatively spliced
fibronectin type III repeats, and a C-terminal fibrinogen-like globular domain.
Several receptors including integrins, EGFR, annexin II, syndecan-4, and toll-like
receptor 4 (TLR-4) bind to the respective domains of TNC and transmit multiple
signals (see [6]). Numerous studies have shown that TNC can control the balance of
cell adhesion and de-adhesion, cell motility, proliferation, differentiation, and
survival (reviewed in [5–7]). Recently, the role of TNC in the modulation of
inflammation is highlighted [8].
Tenascin-C is found in many developing organs, including the cardiovascular
system, but is often restricted transiently to specific sites, for example, near
migrating cells and at sites of epithelial–mesenchymal/mesenchymal–epithelial
transition. In normal adults, tenascin-C expression is sparsely detected; however,
marked expression is seen in injury, regeneration, and cancer at sites where the
tissue structure is being dynamically remodeled. Various factors, including growth
factors and pro-inflammatory cytokines, can activate TNC expression (reviewed in
[9]). It is particularly of interest that mechanical stress is an important inducer of
TNC. Moreover, it is also noteworthy that TNC itself is an elastic molecule and may
contribute to tissue elasticity [10].
As well as in other tissue, the expression of TNC in the normal vascular wall is low
and upregulated in pathological conditions. The major source is medial smooth muscle
cells [11]. However, TNC in the vascular system appears more complex in contrast to
the heart [7]. For example, constitutive expression of TNC is observed in the medial
layer of the abdominal aorta of normal adult mice but not in the thoracic aorta [12].
29.3.1 Development of Aorta and Tenascin-C
The origin of vascular smooth muscle cells (VSMC) of the aorta is heterogeneous
[13]. The second heart field gives rise to VSMC of the root of the aorta. The cardiac
neural crest contributes ascending and arch portions of the aorta. The origin of VSMC
of the descending aorta is more complex. Primitive VSMC of the thoracic aorta
originate from the lateral plate mesoderm and are replaced by cells derived from the
paraxial mesoderm (somites). Moreover, individual somites build up restricted spatial
domains of the “segmental” aortic wall. However, no evident segmental expression
pattern of TNC is observed during development of the aorta. In E12–13 mouse
embryos, very weak expression of TNC is observed in the ascending aorta and
pulmonary truncus. Whereas elastic fibers in the medial layer of the aorta become
mature around E12–13, the expression of TNC is upregulated after ED14–15
(Fig. 29.1) when the systemic circulatory system is established. This upregulated
expression of TNC may reflect the increased hemodynamic stress on the aortic wall.
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29.3.2 Development of Coronary Artery and Tenascin-C
Coronary vessels are formed with the cells originating mostly from extracardiac
tissue known as the proepicardial organ (PE) (see [14] for review). During coronary
development, strong expression of TNC is observed, closely associated with
thickening of the medial layer when the primitive coronary vasculature connects
with the aortic sinuses [15], suggesting a significant role of TNC in maturation of
the wall of coronary arteries. Indeed, TNC accelerates the differentiation of mesen-
chymal cells of PE to smooth muscle cells in culture [15]. Maturation of the
vascular wall is regulated by various signaling pathways. In particular, the
PDGF-BB/PDGFR-β signaling loop is known to be a key regulator of smooth
muscle cell recruitment. In vitro, TNC amplifies crosstalk signaling between
integrin αvβ3 and PDGF receptor (PDGFR) -β in smooth muscle cells, followed
by enhancing cell proliferation and migration [16]. TNC may promote smooth
muscle precursor expansion and differentiation in maturation of the vascular wall
by enhancing PDGF-BB/PDGFR-β signaling (Fig. 29.2).
Tenascin-C in developing aorta 







Fig. 29.1 Expression pattern of TNC during development of the aorta. Whole mount lacZ
staining and histological sections of descending portion of the thoracic aorta of TNC-reporter
mouse embryos at ED12–15. The sections were immunostained with anti-TNC or anti-α-smooth
muscle actin or stained with elastica sirius red
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29.4 Future Direction and Clinical Implications
The characteristic spatiotemporally restricted expression of TNC has suggested its
significant role during embryonic development. Several in vitro functional assays
support this possibility. Although the grossly normal phenotype of knockout mice
suggests the importance of redundancy and compensatory mechanisms during
embryonic development, it is not straightforward to understand its molecular
function. Meanwhile, TNC expression is linked to a range of vascular diseases,
such as aortic aneurysm, acute aortic dissection, and Kawasaki disease (reviewed in
[11, 17], also see Yoshikane et al. in this proceeding). Increasing numbers of studies
have reported that TNC is highly upregulated, associated with inflammation and
destruction of the vascular wall, suggesting that TNC may be a diagnostic bio-
marker. Furthermore, we have succeeded in endovascular treatment of a rat aneu-
rysm model with a TNC-coated coil [18]. Although TNC could contribute to both
favorable and undesirable effects during pathological processes in a context-
dependent manner, it could be a potential therapeutic target for vascular disease.
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Fig. 29.2 Crosstalk signaling between TNC/integrin αvβ3 and PDGF-BB/PDGFR-β in vascular
smooth muscle cells (Adapted from Ref. [7])
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